Download Free Medical Pharmacokinetics PowerPoint Presentation

Pharmacokinetics PowerPoint Presentation

DOWNLOAD MEDICAL POWERPOINT PRESENTATION

About This Presentation

Description : Check out this medical PowerPoint presentation titled "PHARMACOKINETICS".

This medical PowerPoint presentation is about Pharmacokinetics (PK), the study of the movement of drugs within the body, including the absorption, distribution, metabolism, and excretion of drugs. It is a branch of pharmacology that aims to understand the fate of drugs in the body and how their concentrations change over time.

The four main processes of PK are:

Absorption: This refers to the movement of a drug from its site of administration (e.g., mouth, skin, muscle) into the bloodstream. The rate and extent of absorption depend on various factors such as the drugs chemical properties, dosage form, and the presence of food in the stomach.
Distribution: This refers to the movement of a drug from the bloodstream into the bodys tissues and organs. Factors affecting distribution include the drugs ability to cross biological barriers such as the blood-brain barrier and the protein-binding properties of the drug.
Metabolism: This refers to the chemical transformation of a drug in the body, primarily by enzymes in the liver. Metabolism can either make a drug more or less active, and the rate of metabolism can vary widely among individuals due to genetic and environmental factors.
Excretion: This refers to the elimination of drugs and their metabolites from the body. The primary organ of drug excretion is the kidneys, but drugs can also be excreted through the bile, feces, and breath.

PK studies are essential in determining the appropriate dose and dosing schedule for a drug, as well as predicting potential drug-drug interactions and drug toxicity.

Tags : Pharmacokinetics, pharmaceuticals, pharmaceuticals PowerPoint presentations

Published on : Jun 23, 2023 | Views : 1244 | Downloads : 3

Shareable Url :

Embed Code :

Comment

Transcript

Slide 1-

PHARMACOKINETICS “What the body does to the drug”
Slide 2-

Pharmacokinetics (PK) The study of the disposition of a drug The disposition of a drug includes the processes of ADME Absorption Distribution Metabolism Excretion Toxicity
Slide 3-

ADMET
Slide 4-

DRUG R&D Drug discovery and development 10-15 years to develop a new medicine Likelihood of success: 10% Cost $800 million – 1 billion dollars (US)
Slide 5-

Why drugs fail
Slide 6-

Importance of PK studies Patients may suffer: Toxic drugs may accumulate Useful drugs may have no benefit because doses are too small to establish therapy A drug can be rapidly metabolized.
Slide 7-

Routes Of Administration Routes Of Drug Administration Enteral Parenteral Oral Injection Rectal Respiratory Topical
Slide 8-

Absorption The process by which drug proceeds from the site of administration to the site of measurement (blood stream) within the body. Necessary for the production of a therapeutic effect. Most drugs undergo gastrointestinal absorption. This is extent to which drug is absorbed from gut lumen into portal circulation Exception: IV drug administration
Slide 9-

IV vs Oral
Slide 10-

Absorption relies on Passage through membranes to reach the blood passive diffusion of lipid soluble species. The Process
Slide 11-

The Rule of Five - formulation There are more than 5 H-bond donors. The molecular weight is over 500. The LogP is over 5. There are more than 10 H-bond acceptors. Poor absorption or permeation are more likely when:
Slide 12-

Absorption & Ionization Non-ionised drug More lipid soluble drug Diffuse across cell membranes more easily
Slide 13-

First Pass Metabolism Bioavailability: the fraction of the administered dose reaching the systemic circulation Dose Destroyed in gut Not absorbed Destroyed by gut wall Destroyed by liver to systemic circulation
Slide 14-

Determination of bioavailability A drug given by the intravenous route will have an absolute bioavailability of 1 (F=1 or 100% bioavavailable) While drugs given by other routes usually have an absolute bioavailability of less than one. The absolute bioavailability is the area under curve (AUC) non-intravenous divided by AUC intravenous .
Slide 15-

Toxicity The therapeutic index is the degree of separation between toxic and therapeutic doses. Relationship Between Dose, Therapeutic Effect and Toxic Effect. The Therapeutic Index is Narrow for Most Cancer Drugs
Slide 16-

Distribution The movement of drug from the blood to and from the tissues
Slide 17-

DISTRIBUTION Determined by: • partitioning across various membranes •binding to tissue components •binding to blood components (RBC, plasma protein) •physiological volumes
Slide 18-

DISTRIBUTION All of the fluid in the body (referred to as the total body water), in which a drug can be dissolved, can be roughly divided into three compartments: intravascular (blood plasma found within blood vessels) interstitial/tissue (fluid surrounding cells) intracellular (fluid within cells, i.e. cytosol) The distribution of a drug into these compartments is dictated by it's physical and chemical properties
Slide 19-

TOTAL BODY WATER Vascular 3 L 4% BW Extravascular 9 L 13% BW Intracellular 28 L 41% BW
Slide 20-

Distribution Apparent volume of distribution (Vd) = Amt of drug in body/plasma drug conc VOLUME OF DISTRIBUTION FOR SOME DRUGS DRUG Vd (L) cocaine 140 clonazepam 210 amitriptyline 1050 amiodarone ~5000
Slide 21-

Factors affecting drugs Vd Blood flow: rate varies widely as function of tissue Muscle = slow Organs = fast Capillary structure: •Most capillaries are “leaky” and do not impede diffusion of drugs •Blood-brain barrier formed by high level of tight junctions between cells •BBB is impermeable to most water-soluble drugs
Slide 22-

Blood Brain Barrier Disruption by osmotic means Use of endogenous transport systems Blocking of active efflux transporters Intracerebral implantation Etc
Slide 23-

Plasma Protein Binding Many drugs bind to plasma proteins in the blood steam Plasma protein binding limits distribution. A drug that binds plasma protein diffuses less efficiently, than a drug that doesn’t.
Slide 24-

Physiochemical properties-Po/w The Partition coefficient (Po/w) and can be used to determine where a drug likes to go in the body Any drug with a Po/w greater than 1(diffuse through cell membranes easily) is likely be found throughout all three fluid compartments Drugs with low Po/w values (meaning that they are fairly water-soluble) are often unable to cross and require more time to distribute throughout the rest of the body
Slide 25-

Physiochemical Properties-Size of drug The size of a drug also dictates where it can go in the body. Most drugs : 250 and 450 Da MW Tiny drugs (150-200 Da) with low Po/w values like caffeine can passively diffuse through cell membranes Antibodies and other drugs range into the thousands of daltons Drugs >200 Da with low Po/w values cannot passively cross membranes- require specialized protein-based transmembrane transport systems- slower distribution Drugs < thousand daltons with high Po/w values-simply diffuse between the lipid molecules that make up membranes, while anything larger requires specialized transport.
Slide 26-

Elimination The irreversible removal of the parent drugs from the body Elimination Drug Metabolism (Biotransformation) Excretion
Slide 27-

Drug Metabolism The chemical modification of drugs with the overall goal of getting rid of the drug Enzymes are typically involved in metabolism Drug Metabolism More polar (water soluble) Drug Excretion
Slide 28-

From 1898 through to 1910 heroin was marketed as a non-addictive morphine substitute and cough medicine for children. Bayer marketed heroin as a cure for morphine addiction Heroin is converted to morphine when metabolized in the liver METABOLISM
Slide 29-

Phases of Drug Metabolism Phase I Reactions Convert parent compound into a more polar (=hydrophilic) metabolite by adding or unmasking functional groups (-OH, -SH, -NH2, -COOH, etc.) eg. oxidation Often these metabolites are inactive May be sufficiently polar to be excreted readily
Slide 30-

Phases of metabolism Phase II Reactions Conjugation with endogenous substrate to further increase aqueous solubility Conjugation with glucoronide, sulfate, acetate, amino acid
Slide 31-

Mostly occurs in the liver because all of the blood in the body passes through the liver
Slide 32-

The Most Important Enzymes Microsomal cytochrome P450 monooxygenase family of enzymes, which oxidize drugs Act on structurally unrelated drugs Metabolize the widest range of drugs.
Slide 33-

• Found in liver, small intestine, lungs, kidneys, placenta • Consists of > 50 isoforms • Major source of catalytic activity for drug oxidation • It’s been estimated that 90% or more of human drug oxidation can be attributed to 6 main enzymes: • CYP1A2 • CYP2D6 • CYP2C9 • CYP2E1 • CYP2C19 • CYP3A4 In different people and different populations, activity of CYP oxidases differs. CYP family of enzymes
Slide 34-

ppt slide no 34 content not found
Slide 35-

Inhibitors and inducers of microsomal enzymes Inhibitors: cimetidine prolongs action of drugs or inhibits action of those biotransformed to active agents (pro-drugs) Inducers: barbiturates, carbamazepine shorten action of drugs or increase effects of those biotransformed to active agents Blockers: acting on non-microsomal enzymes (MAOI, anticholinesterase drugs)
Slide 36-

Phase II Main function of phase I reactions is to prepare chemicals for phase II metabolism and subsequent excretion Phase II is the true “detoxification” step in the metabolism process.
Slide 37-

Phase II reactions Conjugation reactions Glucuronidation (on -OH, -COOH, -NH2, -SH groups) Sulfation (on -NH2, -SO2NH2, -OH groups) Acetylation (on -NH2, -SO2NH2, -OH groups) Amino acid conjugation (on -COOH groups) Glutathione conjugation (to epoxides or organic halides) Fatty acid conjugation (on -OH groups) Condensation reactions
Slide 38-

Glucuronidation Conjugation to a-d-glucuronic acid Quantitatively the most important phase II pathway for drugs and endogenous compounds Products are often excreted in the bile
Slide 39-

Phase I and II - Summary Products are generally more water soluble These reactions products are ready for (renal) excretion There are many complementary, sequential and competing pathways Phase I and Phase II metabolism are a coupled interactive system interfacing with endogenous metabolic pathways
Slide 40-

Excretion The main process that body eliminates "unwanted" substances. Most common route - biliary or renal Other routes - lung (through exhalation), skin (through perspiration) etc. Lipophilic drugs may require several metabolism steps before they are excreted
Slide 41-

ADME - Summary